These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7049455)

  • 21. Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC).
    Zhang Z; Lipman JM; Diener RM; Thomas P
    Int J Toxicol; 2006; 25(6):487-92. PubMed ID: 17132607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T and B lymphocytes exert distinct effects on the homeostasis of NK cells.
    Jeannet G; Coudert JD; Held W
    Eur J Immunol; 2006 Oct; 36(10):2725-34. PubMed ID: 16955521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired lymphocyte development and function in Clast5/Stra13/DEC1-transgenic mice.
    Seimiya M; Wada A; Kawamura K; Sakamoto A; Ohkubo Y; Okada S; Hatano M; Tokuhisa T; Watanabe T; Saisho H; Tagawa M; O-Wang J
    Eur J Immunol; 2004 May; 34(5):1322-32. PubMed ID: 15114665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune system development and function in prolactin receptor-deficient mice.
    Bouchard B; Ormandy CJ; Di Santo JP; Kelly PA
    J Immunol; 1999 Jul; 163(2):576-82. PubMed ID: 10395643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The multiple molecular forms of acetylcholinesterase in "motor end-plate disease" in the mouse (medJ and med allelic forms): sensitivity of the 10 S form to partial or total loss of muscle activity.
    Rieger F; Shelanski ML; Sidman RL
    Exp Neurol; 1983 Feb; 79(2):299-315. PubMed ID: 6822265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired T cell functions preceding lymphoproliferative disorders in mice neonatally tolerized to transplantation antigens.
    Jánossy T; Vizler C; Ocsovszki I; Tibbe GJ; Pipis J; Savelkoul HF; Végh P; Benner R
    Acta Chir Hung; 1997; 36(1-4):150-1. PubMed ID: 9408323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune functional impairment in patients with clinical abnormalities and silicone breast implants.
    Vojdani A; Campbell A; Brautbar N
    Toxicol Ind Health; 1992; 8(6):415-29. PubMed ID: 7570622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic variables in male and female C57BL/6 mice from two sources.
    Kajioka EH; Andres ML; Nelson GA; Gridley DS
    Comp Med; 2000 Jun; 50(3):288-91. PubMed ID: 10894494
    [No Abstract]   [Full Text] [Related]  

  • 31. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in spleen and thymus cell phenotypes in mice vaccinated with the Coxiella burnetii phase I whole-cell vaccine or the chloroform-methanol residue subunit vaccine.
    Waag DM; Williams JC
    Acta Virol; 1996 Apr; 40(2):87-94. PubMed ID: 8886117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats.
    Guo TL; White KL; Brown RD; Delclos KB; Newbold RR; Weis C; Germolec DR; McCay JA
    Toxicol Appl Pharmacol; 2002 Jun; 181(3):219-27. PubMed ID: 12079431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Dec; 420():1-367. PubMed ID: 12616291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cells determine the outcome of B cell-mediated autoimmunity.
    Shi FD; Wang HB; Li H; Hong S; Taniguchi M; Link H; Van Kaer L; Ljunggren HG
    Nat Immunol; 2000 Sep; 1(3):245-51. PubMed ID: 10973283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of salivary glands extirpation and (or) thymectomy on some physiological and immunological parameters in rats.
    Godzińska E; Paulo E
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):83-8. PubMed ID: 6968196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of high-single-dose alternate-day prednisone on the immunological status of patients with neuromuscular diseases.
    Cook JD; Trotter JL; Engel WK
    Trans Am Neurol Assoc; 1975; 100():177-8. PubMed ID: 1084070
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunogenetics and motor neuron disease.
    Antel JP; Minuk J
    Adv Neurol; 1991; 56():357-67. PubMed ID: 1853768
    [No Abstract]   [Full Text] [Related]  

  • 39. [Suppression of primary immune reaction through L-asparaginase].
    Pappas A; Scheurlen PG
    Verh Dtsch Ges Inn Med; 1971; 77():1165-8. PubMed ID: 4949691
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on the neuromuscular diseases, using neuromuscular junction produced in vitro (preliminary report) (author's transl)].
    Yonezawa T; Hasegawa M; Saida T
    Rinsho Byori; 1974 Apr; 22(4):259-64. PubMed ID: 4472643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.